Literature DB >> 16330530

HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir.

Himanshu Garg1, Robert Blumenthal.   

Abstract

Apoptotic loss of CD4+ T cells has been proposed as a mechanism of T cell depletion in human immunodeficiency virus (HIV) infections resulting in immunodeficiency. The Env glycoprotein has been implicated in apoptosis of uninfected bystander cells via gp120 binding to CD4/CXC chemokine receptor 4 as well as the fusion/hemifusion process mediated by gp41. Using an in vitro model of coculture of Env-expressing cells as effectors and CD4+ T cells as targets, we find that apoptosis mediated by Env glycoprotein in bystander cells in fact correlates with gp41-induced hemifusion. Further, the apoptotic pathway initiated by this interaction involves caspase-3-dependent mitochondrial depolarization and reactive oxygen species production. HIV gp41-induced mitochondrial depolarization is inhibited by protease inhibitor nelfinavir but not by other HIV protease inhibitors or inhibitors of calpain and cathepsin. This "kiss of death" (hemifusion) signaling pathway is independent of p38 mitogen-activated protein kinase and p53, making it distinct from the apoptosis seen in syncytia. We also show that virion-induced apoptosis is gp41-dependent. Our findings provide new insights into the mechanism via which HIV gp41 mediates apoptosis in bystander cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330530     DOI: 10.1189/jlb.0805430

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

Review 1.  HIV protease inhibitors impact on apoptosis.

Authors:  Stacey A Rizza; Andrew D Badley
Journal:  Med Chem       Date:  2008-01       Impact factor: 2.745

2.  Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.

Authors:  Anjali Joshi; Raphael T C Lee; Jonathan Mohl; Melina Sedano; Wei Xin Khong; Oon Tek Ng; Sebastian Maurer-Stroh; Himanshu Garg
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

3.  Emerging Role for Ferroptosis in Infectious Diseases.

Authors:  Eduardo Pinheiro Amaral; Sivaranjani Namasivayam
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41.

Authors:  Xiao Mei Wang; Peter E Nadeau; Yung-Tsun Lo; Ayalew Mergia
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 5.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Authors:  Himanshu Garg; Mathias Viard; Amy Jacobs; Robert Blumenthal
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

6.  HIV ENV glycoprotein-mediated bystander apoptosis depends on expression of the CCR5 co-receptor at the cell surface and ENV fusogenic activity.

Authors:  Anjali Joshi; Alice M Nyakeriga; Revathi Ravi; Himanshu Garg
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

7.  Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.

Authors:  Benjamin J Grady; David C Samuels; Gregory K Robbins; Doug Selph; Jeffrey A Canter; Richard B Pollard; David W Haas; Robert Shafer; Spyros A Kalams; Deborah G Murdock; Marylyn D Ritchie; Todd Hulgan
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-01       Impact factor: 3.731

8.  Reactive Oxygen Species in HIV Infection.

Authors:  Jennifer Couret; Theresa L Chang
Journal:  EC Microbiol       Date:  2016-10-18

9.  Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants.

Authors:  Himanshu Garg; Anjali Joshi; Robert Blumenthal
Journal:  AIDS Res Hum Retroviruses       Date:  2009-08       Impact factor: 2.205

Review 10.  Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.

Authors:  H Garg; R Blumenthal
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.